Table 9.

Comparison between the Core Valve and SAPIEN XT valves.

	Core valve no /%	SAPIEN XT no/%	P value
Procedural and immediate outcome
Procedural success	22/23 (95.7%)	17/17 (100%)	0.869
Second valve	1/23(4.3%)	0/17(0.0%)	0.866
Valve migration	0/23(0.0%)	0/17(0.0%)	1.0
Referral for urgent surgery	0/23(0.0%)	0/17(0.0%)	1.0
Procedural death	0/23(0.0%)	0/17(0.0%)	1.0
Stroke	1/23(4.3%)	0/17(0.0%)	0.866
Bleeding
Minor	3/23 (13.0%)	3/17 (17.6%)	0.964
Major	1/23 (4.3%)	2/17 (11.6%)	0.794
Life threatening	0/23 (0.0%)	0/17 (0.0%)	1.000
Vascular complications
Minor	2/23 (8.6%)	2/17 (11.6%)	0.825
Major	2/23 (8.6%)	1/17 (5.8%)	0.782
At 6 month outcome
Mortality (total)	2/23 (8.6%)	1/17 (5.8%)	0.782
Cardiac	1/23 (4.3%)	0/17 (0.0%)	0.866
Non cardiac	1/23 (4.3%)	1/17 (5.8%)	0.602
Stoke	1/23 (4.3%)	1/17 (5.8%)	0.602
MI	1/23 (4.3%)	0/17 (0.0%)	0.866
New onset AF	2/23 (8.6%)	2/17 (11.6%)	0.825
Permanent pacemaker	4/23 (17.2%)	1/17 (5.8%)	0.550
Paravalvular regurgitation
Non to trace (grade 0)	11/23 (47.85%)	10/17 (58.9%)	0.708
Mild (grade I)	11/23 (47.85%)	7/17 (41.1%)	0.918
Moderate (grade II)	1/23 (4.3%)	0/17 (0.0%)	0.866
Severe (grade III and IV)	0 (0.0%)	0 (0.0%)	1.000
Rehospitalization	1/23 (4.3%)	1/17 (5.8%)	0.602